Herantis Pharma | BioStock Life Science Summit 2024

(14:31)

Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024

(26:37)

Herantis Pharma l COO about initial results from HER-096 with nanoform technology

(6:25)

Henri Huttunen, Herantis Pharma

(23:35)

Herantis Pharma's R\u0026D Update Webinar 26 Oct 2021

(1:4:34)

BIO-Europe Spring® 2018: Herantis CEO outlines development plan for Parkinson's drug

(8:14)

The Parkinson's Virtual Biotech: the search for new treatments

(2:40)

Training and Consulting in Wealth Management - Wealth Engineering for Business Leaders

(19:18)

MUSK PHARMA

(1:11:37)

Haalitko salkkuusi tupakantumppeja, Kyösti Kakkonen?

(1:7:44)

The Fruit That Could Treat Parkinson's Disease?

(3:56)

Updates in Transplant Pharmacotherapy

(57:58)

​Legacy Healthcare - Botanical Drugs

(11:47)

RUCONEST Recombinant Technology and Patient Perspectives

(5:25)

Parkinson's MOOC Launch - Webinar - Wednesday, 5th February 2025

(1:5:8)

Valuation on Herantis Pharma : High risk vs high potential! #stocks #investing

(19)

Herantis Pharma Virtual R\u0026D Investor Day

(1:57:18)

Herantis Pharma as an Investment | Company Night Dec. 13, 2022

(23:41)

BioStock | NLSDays | Herantis Pharma

(3:1econd)

CEO Pekka Simula of Herantis Pharma Plc

(1:39)

Henri Huttunen, Herantis Pharma

(25:14)

CDNF for Parkinson's disease

(5:41)

LSX Nordic Congress 2018: Herantis Pharma CEO Pekka Simula

(12:53)

Herantis Pharma sijoituskohteena | Pörssisijoittajan viikko 10.9.2024

(29:38)

Pekka Simula, CEO of Herantis, interviewed by News Agency Direkt

(8:26)

Herantis Pharma: Disease-modifying drug for Parkinson’s

(7:55)

Herantis Pharma's H1 2022 Report 25 Aug 2022

(44:14)